ப்ரொஃபெஸர் ஷரோன் லெவின் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரொஃபெஸர் ஷரோன் லெவின். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரொஃபெஸர் ஷரோன் லெவின் Today - Breaking & Trending Today

Landmark conference brings the world to Melbourne


After more than two years of extensive planning and preparation, thousands of delegates from 170 countries world-wide converged on Melbourne in July as the city played host to the largest ever health
After more than two years of extensive planning and preparation, thousands of delegates from 170 countries world-wide converged on Melbourne in July as the city played host to the largest ever health conference in Australia – the 20th International AIDS Conference (AIDS 2014). The Conference provides a platform for people working in the field of HIV, policy makers, persons living with HIV and individuals committed to ending the pandemic, to present new scientific knowledge and dialogue on the issues facing the global response to HIV. ....

Anouk Rey , Sharon Lewin , Convention Centre , Club Melbourne Ambassador , Exhibition Centre , Youth Programme , Melbourne Convention , Melbourne Convention Bureau , Professor Sharon Lewin , Convention Bureau , Conference Organiser , Deputy Executive Director , Living Positive , Cultural Events Supervisor , Global Village , Melbourne Declaration , ஷரோன் லெவின் , மாநாடு மையம் , சங்கம் மெல்போர்ன் தூதர் , கண்காட்சி மையம் , இளைஞர்கள் ப்ரோக்ராம் , மெல்போர்ன் மாநாடு , மெல்போர்ன் மாநாடு பணியகம் , ப்ரொஃபெஸர் ஷரோன் லெவின் , மாநாடு பணியகம் , மாநாடு ஆர்கநைஸர் ,

Replication of COVID-19 Virus Can Be Blocked Using CRISPR, Early Lab Tests Show


Researchers have demonstrated that it is possible to use the CRISPR gene-editing tool to stop SARS-CoV-2, the virus responsible for COVID-19, from replicating in infected human cells. The demonstration was done in culture cells in the lab so it is not a forthcoming treatment yet, but this approach could be revolutionary in the medium and long term.
As reported in Nature Communications, the team used the enzyme CRISPR-Cas13b to bind itself to the part of the virus’ genetic code – its RNA – used for replication. The enzyme degrades this bit of information leaving the virus unable to replicate.  
“The flexibility of CRISPR-Cas13 – which only needs the viral sequence – means we can look to rapidly design antivirals for COVID-19 and any new emerging viruses,” senior author Professor Sharon Lewin, from the Peter Doherty Institute for Infection and Immunity in Australia, said in a statement. ....

Emmanuelle Charpentier , Mohamed Fareh , Sharon Lewin , Jennifer Doudna , Nature Communications , University Of Melbourne , Peter Doherty Institute For Infection , Professor Sharon Lewin , Peter Doherty Institute , இம்மானுவேல் சார்பென்டிர் , ஷரோன் லெவின் , இயற்கை தகவல்தொடர்புகள் , பல்கலைக்கழகம் ஆஃப் மெல்போர்ன் , பீட்டர் டோவர்டீ நிறுவனம் க்கு தொற்று , ப்ரொஃபெஸர் ஷரோன் லெவின் , பீட்டர் டோவர்டீ நிறுவனம் ,

Cutting up COVID: Doherty, Peter Mac working on new anti-viral technique


Cutting up COVID: Doherty, Peter Mac working on new anti-viral technique
We’re sorry, this service is currently unavailable. Please try again later.
Dismiss
Normal text size
Advertisement
Melbourne-based scientists have developed a new anti-viral technique that can be quickly tweaked to target viruses including COVID-19 – an important step on the path towards new pandemic defences.
The drug is at the earliest stage of development, and has not even been tested on animals - suggesting it is unlikely to be of use in the current pandemic.
But scientists, including Nobel laureate Professor Peter Doherty, have long been calling for investment in so-called “broad-based anti-virals”, drugs that could immediately fight new pandemics as they emerge. ....

Sharon Lewin , Nature Communications , Doherty Institute , Peter Maccallum Cancer Centre , Professor Sharon Lewin , ஷரோன் லெவின் , இயற்கை தகவல்தொடர்புகள் , டோவர்டீ நிறுவனம் , பீட்டர் மக்காலம் புற்றுநோய் மையம் , ப்ரொஃபெஸர் ஷரோன் லெவின் ,